Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O4KI
|
||||
Former ID |
DNC008472
|
||||
Drug Name |
2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529419] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H9N3S2
|
||||
Canonical SMILES |
CCC1=NC2=C(C(=N1)C3=NC=CS3)SC=C2
|
||||
InChI |
1S/C11H9N3S2/c1-2-8-13-7-3-5-15-10(7)9(14-8)11-12-4-6-16-11/h3-6H,2H2,1H3
|
||||
InChIKey |
YNBYJWXOQPYWEM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [529419] | |
Adenosine A1 receptor | Target Info | Inhibitor | [529419] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [529419] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [529419] | ||
KEGG Pathway | cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.